Broadway Financial Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Broadway Financial heeft totale activa van $1.4B en een totaal eigen vermogen van $286.4M. De totale stortingen zijn $672.2M |number_shorten( $966.8M. Het verdient een netto rentemarge van 2.6%. Er is voldoende voorziening voor slechte leningen, die momenteel 0.03% van de totale leningen bedragen. Contant geld en kortetermijninvesteringen zijn $97.1M.

Belangrijke informatie

4.8x

Verhouding activa / eigen vermogen

2.6%

Nettorentemarge

Totaal deposito's	US$672.25m
Verhouding leningen/deposito's	Hoog
Slechte leningen	0.03%
Voorziening voor dubieuze leningen	Voldoende
Huidige ratio	Laag
Geldmiddelen en kasequivalenten	US$97.08m

Recente financiële gezondheidsupdates

Recent updates

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse financiële instellingen

Activa niveau: De Vermogen/vermogensverhouding ( 4.8 x) BYFC is laag.

Voorziening voor slechte leningen: BYFC heeft een voldoende voorziening voor slechte leningen ( 2930 %).

Laag risico verplichtingen: 62% van de verplichtingen van BYFC bestaan voornamelijk uit laag risico financieringsbronnen.

Leenniveau: BYFC heeft een passend niveau van Leningen/activa-ratio ( 70% ).

Laag risico deposito's: De leningen-depositoverhouding ( 144% ) van BYFC } is hoog.

Niveau van slechte leningen: BYFC heeft een passend niveau van slechte leningen ( 0 %).

Broadway Financial Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Broadway Financial Corporation Announces Notification from Nasdaq Regarding Late Filing of Form 10-Q

Broadway Financial Corporation Announces Notification from Nasdaq Regarding Late Filing of Form 10-Q and Form 10-K

Broadway Financial Corporation announced delayed 10-Q filing

Broadway Financial Receive Written Notice from Nasdaq Regarding Non-Compliance with the Periodic Financial Reporting Requirements Set in Nasdaq Listing Rule 5250(c)(1)

Broadway Financial Corporation announced delayed annual 10-K filing

Broadway Financial Receives an Extension from the Nasdaq Stock Market

Recent updates

Third quarter 2024 earnings released: US$0.03 loss per share (vs US$0.01 profit in 3Q 2023)

Investor sentiment improves as stock rises 23%

New minor risk - Share price stability

Investor sentiment improves as stock rises 17%

Insufficient new directors

Broadway Financial Corporation Announces Notification from Nasdaq Regarding Late Filing of Form 10-Q

Broadway Financial Corporation Announces Management Changes

Broadway Financial Corporation Announces Notification from Nasdaq Regarding Late Filing of Form 10-Q and Form 10-K

Broadway Financial Corporation announced delayed 10-Q filing

Broadway Financial Receive Written Notice from Nasdaq Regarding Non-Compliance with the Periodic Financial Reporting Requirements Set in Nasdaq Listing Rule 5250(c)(1)

Broadway Financial Corporation announced delayed annual 10-K filing

New minor risk - Financial data availability

High number of new directors

Broadway Financial Receives an Extension from the Nasdaq Stock Market

Broadway Financial Receives Written Notice from the Nasdaq Stock Market

Broadway Financial Corporation announced delayed 10-Q filing

Broadway Financial Receives Non-Compliance Notice From Nasdaq Stock Market LLC

Brenda Battey Intends to Retire as Chief Financial Officer of Broadway Financial Corporation

Second quarter 2023 earnings released: EPS: US$0.003 (vs US$0.025 in 2Q 2022)

High number of new directors

Broadway Financial Corporation announced delayed 10-Q filing

Full year 2022 earnings released: EPS: US$0.077 (vs US$0.067 loss in FY 2021)

Investor sentiment deteriorates as stock falls 20%

Full year 2022 earnings released: EPS: US$0.08 (vs US$0.067 loss in FY 2021)

Investor sentiment improves as stock rises 25%

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: US$0.018 (vs US$0.003 in 3Q 2021)

High number of new directors

Third quarter 2022 earnings released: EPS: US$0.02 (vs US$0.003 in 3Q 2021)

Investor sentiment improved over the past week

Broadway Financial Corporation, Annual General Meeting, Oct 19, 2022

Second quarter 2022 earnings released: EPS: US$0.03 (vs US$0.01 in 2Q 2021)

Broadway Financial GAAP EPS of $0.03, revenue of $8.3M

High number of new directors

Broadway Financial Corporation announced that it has received $150 million in funding from United States Department of The Treasury

Broadway Financial Corporation Announces the Election of John Driver to the Board of Directors

Broadway Financial Corporation announced delayed annual 10-K filing

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS US$0.003 (vs US$0.009 loss in 3Q 2020)

High number of new directors

High number of new directors

High number of new directors

Broadway Financial Corporation announced delayed 10-Q filing

First quarter 2021 earnings released: US$0.13 loss per share (vs US$0.001 loss in 1Q 2020)

Broadway Financial reports Q1 results

Independent Chairman of the Board Virgil Roberts has left the company

Independent Director has left the company

Independent Director has left the company

Broadway Financial Corporation announced that it has received $32.88372 million in funding from a group of investors

New 90-day high: US$2.42

New 90-day high: US$2.28

New 90-day high: US$2.03

Broadway Financial rallies on regulatory nod for merger with CFBanc

Third quarter 2020 earnings released: US$0.01 loss per share

Third quarter 2020 earnings released: US$0.009 loss per share

Broadway Financial Corporation (NasdaqCM:BYFC) entered into merger of equals agreement to acquire CFBanc Corporation for $39.6 million.

New 90-day low: US$1.47

The Capital Corps, LLC acquired 6.8% stake in Broadway Financial Corporation (NasdaqCM:BYFC) from United States Department of the Treasury.

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse financiële instellingen

Ontdek gezonde bedrijven